(Q40122807)
Statements
BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts (English)
Kohl TM
Hellinger C
Buske C
Hiddemann W
Spiekermann K
1 reference